Skip to main content

Table 1 Factors associated with absenteeism, presenteeism and axSpA-related job loss in a population of patients receiving biologics

From: Amongst patients taking biologic therapies for axial spondyloarthritis, which factors are associated with work non-participation?

Factors

Current workers (n = 101)

Currently eligible to work (n = 118)

Absenteeism (Completed by n = 74)

Presenteeism (Completed by n = 73)

 

None reported (n = 66) (%)

Absent in past week (n = 8) (%)

p-value

crude OR (95%CI)

≤40% (n = 62) (%)

> 40% (n = 11) (%)

p-value

crude OR (95%CI)

Currently working (n = 101)(%)

axSpA related job loss (n = 17)(%)

p-value

crude OR (95%CI)

Age (years)

45.3 (1.3)

36.9 (3.3)

0.03

 

45.8 (1.4)

39.1 (2.7)

0.04

 

45.0 (1.1)

48.3 (2.2)

0.26

 

Males, N(%)

49 (74.2)

5 (62.5)

0.48

 

47 (73.4)

9 (69.2)

0.76

 

76 (75.3)

13 (76.5)

0.91

 

Current smoker, N(%)

17 (26.2)

4 (57.1)

0.09

 

12 (19.7)

8 (80.0)

< 0.001

 

26 (26.5)

5 (29.4)

0.81

 

Time between diagnosis and treatment, Median (IQR)

5.6 (0.9,14.6)

1.9 (0.7,4.6)

0.21

 

6.8 (1.2,17.5)

0.8 (0.05,1.9)

0.004

 

5.6 (1.3,15.4)

4.5 (0.8,13.7)

0.79

 

N treatmenta

 1

45 (79.0)

2 (40.0)

0.14

 

43 (79.6)

3 (37.5)

0.04

 

60 (76.0)

9 (52.9)

0.003

 

 2

9 (15.8)

2 (40.0)

  

8 (14.8)

4 (50.0)

  

14 (17.7)

2 (11.8)

  

 3 or 4

3 (5.3)

1 (20.0)

  

3 (5.6)

1 (12.5)

  

5 (6.3)

6 (35.3)

  

BASDAI, Median (IQR)

3.0 (1.6,4.7)

3.9 (2.4,7.0)

0.15

1.4 (0.9,2.0)

2.6 (1.6,4.1)

5.4 (4.7,7.4)

< 0.001

2.5 (1.6,4.1)

3 (1.6,5.1)

7.2 (5.9,8.0)

< 0.001

2.3 (1.6,3.5)

BASFI, Median (IQR)

2.4 (1.5,4.1)

4.2 (2.6,7.7)

0.08

1.4 (1.0,2.0)

2.1 (1.2,3.3)

5.3 (4.5,7.3)

< 0.001

2.0 (1.4,2.9)

2.8 (1.7,4.5)

7.4 9 (6.7,9.0)

< 0.001

2.6 (1.6,4.2)

BASMI, Median (IQR)

3.2 (1.6,4.6)

2.6b

0.83

0.8 (0.2,3.4)

3.0 (1.6,4.0)

2.6 (1.0,4.2)

0.69

0.8 (0.4,2.0)

2.8 (1.6,4.0)

6.0 (5.4,6.6)

0.01

9.3 (0.8112.7)

BASG, Median (IQR)

3.0 (1.0,4.0)

4.0 (1.0,7.0)

0.41

1.2 (0.9,1.7)

2.0 (1.0,3.0)

6.0 (4.5,8.5)

< 0.001

2.0 (1.4,2.9)

3.0 (1.0,5.0)

7.0 (6.0,9.0)

< 0.001

2.2 (1.5,3.1)

ASQoL, Median (IQR)

4.0 (1.0,8.0)

10.0 (4.0,16.0)

0.01

1.3 (1.1,1.5)

4.0 (0,7.0)

12.0 (9.30,17.0)

< 0.001

1.5 (1.2,1.8)

4.0 (2.0,8.0)

15.0 (12.5,16.0)

< 0.001

1.4 (1.2,1.7)

  1. aData for number of treatments were not available for 12 patients (absenteeism analysis); 11 patients (presenteeism analysis). bOnly one patient with sickness absence had BASMI recorded
Back to article page

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us